Bullboard - Stock Discussion Forum Perspective Therapeutics Inc CATX

Healthcare Biotechnology

Perspective Therapeutics, Inc. is a radiopharmaceutical development company that is developing advanced treatment applications for cancers throughout the body. The Company has proprietary technology that utilizes the alpha-emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides. It is also developing imaging diagnostics that... see more

Add To Watchlist

NYSEAM:CATX - Post Discussion

Perspective Therapeutics Inc > Perspective Therapeutics to Pursue Dose Escalation of [212Pb

View:

Post by whytestocks on Nov 21, 2024 5:16pm

Perspective Therapeutics to Pursue Dose Escalation of [212Pb

BREAKING NEWS: $CATX Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-?-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium[ 212 Pb]VMT-α-NET continued to have a favorable safety profile, with no dose-limiting toxicities observed at the two doses tested (2.5 and 5.0 mCi) Eight of nine patients had durable control of disease. Six of nine patients had a measurable reduction of tumor volume, o...CATX - Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-?-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium